Program

Home

Controversies in initial therapy of HIV-infected treatment experienced children, focused o

Website foto Wiznia

Andrew Wiznia , MD. is a Professor of Pediatrics at the Albert Einstein College of Medicine (AECOM) and the Director of HIV Services at the Jacobi Medical Center, both located in the Bronx, New York. He has been providing care to HIV infected children and their families for 24 years, initially as an allergy/immunology fellow at AECOM. He is currently the
 Domestic Vice Chair of the Primary Therapy Research Committee of the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group and is the Site Principal Investigator on numerous multicenter NIH and CDC funded trials investigating HIV infected and affected children.  He has been the co-chair of numerous protocols conducted by the Pediatric AIDS Clinical Trials Group and IMPAACT.
He has published extensively on the treatment of HIV infected children including phase I/II trials, strategy trials, immunologic consequences and complications associated with HIV infection. He is also the Co-Chairperson of the Research Committee of the New York City Health and Hospital Corporation.